These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14643568)

  • 1. Quetiapine in the elderly with parkinsonism and psychosis.
    Wijnen HH; van der Heijden FM; van Schendel FM; Tuinier S; Verhoeven WM
    Eur Psychiatry; 2003 Nov; 18(7):372-3. PubMed ID: 14643568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating psychosis in Parkinson's disease with atypical antipsychotics.
    Duggal HS; Singh I
    Eur Psychiatry; 2005 Jan; 20(1):83-4. PubMed ID: 15642454
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism.
    Chen JJ; Hua H; Massihi L; Portillo I; Alipour A; Ondo W; Dashtipour K
    J Neuropsychiatry Clin Neurosci; 2019; 31(3):188-195. PubMed ID: 30848989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of quetiapine fumarate on drug-induced psychosis in patients with Parkinson's disease].
    Kohmoto J; Kihira T; Miwa H; Kondo T
    No To Shinkei; 2002 Jun; 54(6):489-92. PubMed ID: 12166098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of psychosis in elderly patients with parkinsonism.
    Hasnain M; Vieweg WV; Baron MS; Beatty-Brooks M; Fernandez A; Pandurangi AK
    Am J Med; 2009 Jul; 122(7):614-22. PubMed ID: 19559160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotics and mortality in Parkinsonism.
    Marras C; Gruneir A; Wang X; Fischer H; Gill SS; Herrmann N; Anderson GM; Hyson C; Rochon PA
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):149-58. PubMed ID: 22273735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
    Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A
    Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review.
    Desmarais P; Massoud F; Filion J; Nguyen QD; Bajsarowicz P
    J Geriatr Psychiatry Neurol; 2016 Jul; 29(4):227-36. PubMed ID: 27056066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of quetiapine for treatment of geriatric psychosis.
    Yang CH; Tsai SJ; Hwang JP
    J Psychopharmacol; 2005 Nov; 19(6):661-6. PubMed ID: 16272189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
    Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
    Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term use of quetiapine in elderly patients with psychotic disorders.
    Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW
    Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
    Menza MM; Palermo B; Mark M
    Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine in the successful treatment of psychosis and comorbid brittle diabetes mellitus: a case report.
    Balter J; Mofsen R; Pinninti N
    Int J Psychiatry Med; 2004; 34(3):259-66. PubMed ID: 15666960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
    Mullen J; Jibson MD; Sweitzer D
    Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency.
    Potvin S; Stip E; Roy JY
    Can J Psychiatry; 2004 Oct; 49(10):711. PubMed ID: 15560324
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
    Citrome L; Krakowski M; Greenberg WM; Andrade E; Volavka J
    J Clin Psychiatry; 2001 Nov; 62(11):901. PubMed ID: 11775051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.